ThermoGenesis Holdings, Inc. (THMO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 15, 2025, 3:16 PM EDT
ThermoGenesis Holdings Market Cap
ThermoGenesis Holdings has a market cap or net worth of $1.59 thousand as of August 15, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
1.59K
Enterprise Value
4.33M
Revenue
9.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 1, 1992, ThermoGenesis Holdings's market cap has decreased from 16.75M to 1.59K, a decrease of -99.99%. That is a compound annual growth rate of -24.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 1.59K | -85.71% |
| Dec 31, 2024 | 11.09K | -99.41% |
| Dec 29, 2023 | 1.89M | -42.37% |
| Dec 30, 2022 | 3.27M | -72.81% |
| Dec 31, 2021 | 12.03M | -26.16% |
| Dec 31, 2020 | 16.29M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |